Suche >
3,5-Difluoro-2-methoxybenzamide
Drucken
Sie suchten nach:
22 673 results were found
3,5-Difluoro-2-methoxybenzamide
Artikel-Nr:
(GERI0857)
Lieferant:
GERING
Hersteller-Artikelnummer::
0857
Lokale Artikelnummer::
GERI0857
Beschreibung:
Alcohol meters for special applications.
VE:
1 * 1 ST
Lieferant:
Sigma-Aldrich
Beschreibung:
3',5'-Dimethoxy-4'-hydroxyacetophenon, Sigma-Aldrich®
Artikel-Nr:
(EHERC16430000)
Lieferant:
EHRENSTORFER
Hersteller-Artikelnummer::
C16430000
Lokale Artikelnummer::
EHERC16430000
Beschreibung:
Propargit
VE:
1 * 0,1 g
Lieferant:
Avantor Fluid Handling
Beschreibung:
Output signal for local and remote indication.
Artikel-Nr:
(HECH42990034)
Lieferant:
GLASWARENFABRIK KARL HECHT
Hersteller-Artikelnummer::
42990034
Lokale Artikelnummer::
HECH42990034
Beschreibung:
High-density polyethylene.
VE:
1 * 1 ST
Artikel-Nr:
(WITG4.947.002)
Lieferant:
WITEG LABORTECHNIK
Hersteller-Artikelnummer::
4.947.002
Lokale Artikelnummer::
WITG4.947.002
Beschreibung:
DURAN®, borosilicate glass.
VE:
1 * 1 ST
Lieferant:
WITEG LABORTECHNIK
Beschreibung:
Edelstahl.
Lieferant:
Integra
Beschreibung:
Ansaugschlauch, Dispensierschlauch, Edelstahl, eine Seite eingekerbt, Länge: 35 cm, Für: Mikrobiologisches Liquid-Handling-System, DOSE IT
Artikel-Nr:
(217-9132)
Lieferant:
DWK Life Sciences
Hersteller-Artikelnummer::
216241106
Lokale Artikelnummer::
SCOT216241106
Beschreibung:
Diese Stopfen aus Borosilikatglas 3.3 haben einen achteckigen Kopf für einen guten Griff.
VE:
1 * 1 ST
Artikel-Nr:
(PRSI96-337)
Lieferant:
ProSci Inc.
Hersteller-Artikelnummer::
96-337
Lokale Artikelnummer::
PRSI96-337
Beschreibung:
Galectin-3 (Gal-3) is also known as LGALS3, 35 kDa lectin, Carbohydrate-binding protein 35 (CBP 35), Galactose-specific lectin 3, Galactoside-binding protein (GALBP), IgE-binding protein, Laminin-binding protein, Mac-2 antigen, Lectin L-29. Galectin-3 is a member of the lectin family. LGALS3 / Galectin-3 is expressed in the nucleus, cytoplasm, mitochondrion, cell surface, and extracellular space. LGALS3 / Galectin-3 has been shown to be involved in the following biological processes: cell adhesion, cell activation and chemoattraction, cell growth and differentiation, cell cycle, and apoptosis.
VE:
1 * 200 µG
Lieferant:
Biotium
Beschreibung:
Recognizes a DQ antigen, which is a dimer of 60 kDa. The class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B Lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa. It is encoded by 5 exons; exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. Within the DQ molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to four different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation.This MAb strongly blocks cytotoxicity activity of T4-positive cytotoxic T cell clones.
Lieferant:
Biotium
Beschreibung:
Recognizes a DQ antigen, which is a dimer of 60 kDa. The class II molecule is a heterodimer consisting of an alpha (DQA) and a beta chain (DQB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B Lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa. It is encoded by 5 exons; exon 1 encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, and exon 4 encodes the transmembrane domain and the cytoplasmic tail. Within the DQ molecule both the alpha chain and the beta chain contain the polymorphisms specifying the peptide binding specificities, resulting in up to four different molecules. Typing for these polymorphisms is routinely done for bone marrow transplantation.This MAb strongly blocks cytotoxicity activity of T4-positive cytotoxic T cell clones.
Artikel-Nr:
(BOSSBS-13235R-A350)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-13235R-A350
Lokale Artikelnummer::
BOSSBS-13235R-A350
Beschreibung:
This reference sequence was derived from multiple replicate ESTs and validated by similar human genomic sequence. This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. This gene product, FXYD7, is novel and has not been characterized as a protein. [RefSeq curation by Kathleen J. Sweadner, Ph.D., sweadner@helix.mgh.harvard.edu., Dec 2000].
VE:
1 * 100 µl
Artikel-Nr:
(BOSSBS-12883R-A750)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-12883R-A750
Lokale Artikelnummer::
BOSSBS-12883R-A750
Beschreibung:
The breast cancer susceptibility gene (BRCA1) localizes to chromosome 17q. Mutations within this gene account for approximately 45% of families with high incidence of breast cancer and at least 80% of families with increased incidence of both early-onset breast cancer and ovarian cancer. A second breast cancer susceptibility gene, BRCA2, located on chromosome 13q12-13, also confers a high incidence of breast cancer, but unlike BRCA1, BRCA2 does not confer a substantially elevated risk of ovarian cancer. The BRCA2-Associated Factor 35 (BRAF35) protein forms a complex with BRCA2, which associates with condensed chromatin during histone H3 phosphorylation. BRAF35 expression levels are highest in proliferating tissues and parallel BRCA2 expression patterns. The structure of BRAF35 includes a kinesin-like coiled coil domain and a nonspecific DNA binding HMG domain. The chromatin localisation of BRAF35 and antibody microinjection studies indicate a role for the BRAF35/BRCA2 complex in cell cycle regulation.
VE:
1 * 100 µl
Artikel-Nr:
(BOSSBS-12883R-CY7)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-12883R-CY7
Lokale Artikelnummer::
BOSSBS-12883R-CY7
Beschreibung:
The breast cancer susceptibility gene (BRCA1) localizes to chromosome 17q. Mutations within this gene account for approximately 45% of families with high incidence of breast cancer and at least 80% of families with increased incidence of both early-onset breast cancer and ovarian cancer. A second breast cancer susceptibility gene, BRCA2, located on chromosome 13q12-13, also confers a high incidence of breast cancer, but unlike BRCA1, BRCA2 does not confer a substantially elevated risk of ovarian cancer. The BRCA2-Associated Factor 35 (BRAF35) protein forms a complex with BRCA2, which associates with condensed chromatin during histone H3 phosphorylation. BRAF35 expression levels are highest in proliferating tissues and parallel BRCA2 expression patterns. The structure of BRAF35 includes a kinesin-like coiled coil domain and a nonspecific DNA binding HMG domain. The chromatin localization of BRAF35 and antibody microinjection studies indicate a role for the BRAF35/BRCA2 complex in cell cycle regulation.
VE:
1 * 100 µl
Artikel-Nr:
(BOSSBS-12883R-CY3)
Lieferant:
Bioss
Hersteller-Artikelnummer::
BS-12883R-CY3
Lokale Artikelnummer::
BOSSBS-12883R-CY3
Beschreibung:
The breast cancer susceptibility gene (BRCA1) localizes to chromosome 17q. Mutations within this gene account for approximately 45% of families with high incidence of breast cancer and at least 80% of families with increased incidence of both early-onset breast cancer and ovarian cancer. A second breast cancer susceptibility gene, BRCA2, located on chromosome 13q12-13, also confers a high incidence of breast cancer, but unlike BRCA1, BRCA2 does not confer a substantially elevated risk of ovarian cancer. The BRCA2-Associated Factor 35 (BRAF35) protein forms a complex with BRCA2, which associates with condensed chromatin during histone H3 phosphorylation. BRAF35 expression levels are highest in proliferating tissues and parallel BRCA2 expression patterns. The structure of BRAF35 includes a kinesin-like coiled coil domain and a nonspecific DNA binding HMG domain. The chromatin localization of BRAF35 and antibody microinjection studies indicate a role for the BRAF35/BRCA2 complex in cell cycle regulation.
VE:
1 * 100 µl
Preis auf Anfrage
Lager für diesen Artikel ist begrenzt, kann aber in einem Lagerhaus in Ihrer Nähe zur Verfügung. Bitte stellen Sie sicher, dass Sie in sind angemeldet auf dieser Seite, so dass verfügbare Bestand angezeigt werden können. Wenn das
 noch angezeigt wird und Sie Hilfe benötigen, rufen Sie uns an 1-800-932 - 5000.
Lager für diesen Artikel ist begrenzt, kann aber in einem Lagerhaus in Ihrer Nähe zur Verfügung. Bitte stellen Sie sicher, dass Sie in sind angemeldet auf dieser Seite, so dass verfügbare Bestand angezeigt werden können. Wenn das
noch angezeigt wird und Sie Hilfe benötigen, rufen Sie uns an 1-800-932 - 5000.
Dieses Produkt kann nur an eine Lieferadresse versandt werden die über die entsprechende Lizenzen verfügt. Für weitere Hilfe bitte kontaktieren Sie Ihr VWR Vertriebszentrum.
-Additional Documentation May be needed to purchase this item. A VWR representative will contact you if needed.
Dieses Produkt wurde von Ihrer Organisation gesperrt. Bitte kontaktieren Sie Ihren Einkauf für weitere Informationen.
Dieses Produkt ist Ersatz für den von Ihnen gewünschten Artikel.
Dieses Produkt ist nicht mehr verfügbar. Bitte kontaktieren Sie den VWR Kundenservice.
|
|||||||||
Listenansicht
